Kim RB - Search Results

1

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.

Dresser GK, Schwarz UI, Wilkinson GR, Kim RB. Dresser GK, et al. Among authors: kim rb. Clin Pharmacol Ther. 2003 Jan;73(1):41-50. doi: 10.1067/mcp.2003.10. Clin Pharmacol Ther. 2003. PMID: 12545142 Clinical Trial.

2

Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.

Kim RB, O'Shea D. Kim RB, et al. Clin Pharmacol Ther. 1995 Jun;57(6):645-55. doi: 10.1016/0009-9236(95)90227-9. Clin Pharmacol Ther. 1995. PMID: 7781264

3

Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.

Kim RB, O'Shea D, Wilkinson GR. Kim RB, et al. Pharmacogenetics. 1994 Jun;4(3):162-5. Pharmacogenetics. 1994. PMID: 7920697 No abstract available.

4

Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.

O'Shea D, Davis SN, Kim RB, Wilkinson GR. O'Shea D, et al. Among authors: kim rb. Clin Pharmacol Ther. 1994 Oct;56(4):359-67. doi: 10.1038/clpt.1994.150. Clin Pharmacol Ther. 1994. PMID: 7955797

5

In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.

Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Guengerich FP, Ishizaki T, Shimada T, Wilkinson GR. Kim RB, et al. J Pharmacol Exp Ther. 1996 Oct;279(1):4-11. J Pharmacol Exp Ther. 1996. PMID: 8858968

6

CYP2E1 activity is not altered by influenza vaccination.

Kim RB, Wilkinson GR. Kim RB, et al. Br J Clin Pharmacol. 1996 Oct;42(4):529-30. doi: 10.1111/j.1365-2125.1996.tb00022.x. Br J Clin Pharmacol. 1996. PMID: 8904631 Free article. No abstract available.

7

Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.

O'Shea D, Kim RB, Wilkinson GR. O'Shea D, et al. Among authors: kim rb. Br J Clin Pharmacol. 1997 Jan;43(1):99-103. doi: 10.1111/j.1365-2125.1997.tb00039.x. Br J Clin Pharmacol. 1997. PMID: 9056059 Free article.

8

Characterization of the hepatic canalicular membrane transport of a model oligopeptide: ditekiren.

Takahashi H, Kim RB, Perry PR, Wilkinson GR. Takahashi H, et al. Among authors: kim rb. J Pharmacol Exp Ther. 1997 Apr;281(1):297-303. J Pharmacol Exp Ther. 1997. PMID: 9103510

9

High affinity uptake by isolated rat hepatocytes of a linear pseudo-hexapeptide, ditekiren.

Kim RB, Perry PR, Wilkinson GR. Kim RB, et al. Biochim Biophys Acta. 1997 Aug 14;1328(1):41-7. doi: 10.1016/s0005-2736(97)00071-0. Biochim Biophys Acta. 1997. PMID: 9298943 Free article.

10

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR. Kim RB, et al. J Clin Invest. 1998 Jan 15;101(2):289-94. doi: 10.1172/JCI1269. J Clin Invest. 1998. PMID: 9435299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters